Dexamethasone Implant Anterior Chamber Migration: Risk Factors, Complications, and Management Strategies – Corrected Proof

Objective: To describe the risk factors, clinical course, and complications of migration of a dexamethasone (DEX) intravitreal implant (OZURDEX; Allergan, Inc., Irvine, CA) into the anterior chamber and subsequent management strategies.Design: Retrospective, observational case series.Participants: Fifteen patients had 18 episodes of migration of the DEX implant into the anterior chamber.Methods: The medical records of 15 patients with spontaneous migration of a DEX implant were retrospectively reviewed.Main Outcome Measures: Migration of the DEX implant into the anterior chamber.Results: Migration of a DEX intravitreal implant into the anterior chamber occurred in 6 patients who were aphakic, 4 patients with an anterior chamber (Read more...)

Full Story →